Malignant granular cell tumor: case report with a novel karyotype and review of the literature.

Department of Pathology, St John Hospital and Medical Center, Detroit, MI 48236, USA.
Annals of diagnostic pathology (Impact Factor: 1.11). 08/2010; 14(4):273-8. DOI: 10.1016/j.anndiagpath.2009.08.004
Source: PubMed

ABSTRACT Malignant granular cell tumor is a rare neoplasm reported to occur at various sites in the body. Histogenesis of these tumors is still vaguely understood; however, their metastatic potential and adverse prognosis is well-described in the literature. The histologic criteria of malignancy proposed by Fanburg-Smith et al are still debatable amongst pathologists, with metastasis being the sole criterion of malignancy with unanimous agreement. To our knowledge, no specific karyotype characterizes these tumors. Hence, the importance of detecting characteristic cytogenetic alterations in these tumors which might serve, in the future, as a possible aid in diagnosis or therapy. We report a new case of malignant granular cell tumor of the thigh with metastases to abdominal wall and both lungs causing severe dyspnea. Cytogenetic analysis demonstrated that 60% of cultured tumor cells display the following karyotype 46,XX,+X,dic(5;15).

  • [Show abstract] [Hide abstract]
    ABSTRACT: Granular cell tumors (GCTs) in esophagus are rare tumors lacking of systemic large group reports. In this study, we summarized the clinical characteristics, histological features and therapeutic approaches of 31 cases. GCTs generally located at middle and distal of the esophagus in middle aged and elderly patients with no incidence of gender differences. Histologically, tumor cells were mainly plump and polygonal with abundant, granular, amphophilic or eosinophilic cytoplasm. The growth pattern was solid or nested, usually with minimal infiltration and inflammatory infiltrates and lymphoid aggregation. All GCTs in the present study were benign according to Nasser criteria. Nestin, NSE, CD68 and S100 protein were moderate to strong positive. Moreover, a developmental morphology of a GCT was found, which included areas of relatively normal Schwann cells, transitional cells and typical cells of GCTs. All patients received endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD). Twenty-six patients were followed up and remained clinically well. In conclusion, GCTs of esophagus are neurogenic origin tumors with favourable prognosis. Definite diagnosis of GCTs relies upon pathological examination. The Nasser criteria for stratification are practical in guiding treatment strategy. ESD is a recommended therapeutic strategy, and the range of application is expanding.
    International journal of clinical and experimental pathology. 01/2014; 7(7):4000-7.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The granular cell tumor (GCT) is a rare, benign tumor that most commonly occurs in the oral cavity, particularly in the anterior part of the tongue. In this study the experience with 16 patients with a GCT observed in a single Institution will be discussed. Although no radicality has been obtained in most cases, recurrences are rare. In one patient, a recurrence was noted four years after excision of the primary. In the same patient a pulmonary lesion occurred five years after excision of the recurrence in the oral cavity, most likely representing an example of metachronous occurrence and not a distant metastasis. Since recurrences and metachronous lesions are rare, as are distant metastases, routine follow-up does not seem warranted in patients treated for a granular cell tumor of the oral cavity.
    Medicina oral, patologia oral y cirugia bucal 06/2014; · 1.10 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this study was to assess loss of heterozygosity (LOH) in tumor suppressor gene loci in oral granular cell tumors (GCTs). We assessed LOH in 8 samples of oral GCT using polymorphic microsatellite markers at chromosome regions 3p, 9p, 11q, and 17p, flanking areas close to tumor suppressor genes. We further performed immunohistochemistry to detect the p53 and Ki-67 proteins and associated these expressions with the molecular results. Five samples showed LOH in 3 markers at chromosomes 9p and 17p (markers P53, AFM238WF2 and D9S162) with fraction of allelic loss of 42.8% for each of these markers. No LOH was identified in any other chromosome. LOH was not associated with the immunohistochemical expression of p53 and Ki-67. The present study shows LOH at chromosomes 9p and 17p in oral GCTs.
    Oral surgery, oral medicine, oral pathology and oral radiology. 02/2013; 115(2):249-53.